Men treated for prostate cancer who took aspirin regularly for other medical conditionswere less likely to die of their cancer than patients who weren’t taking aspirin, according to a new study. Andrew T. Chan, HMS associate professor of medicine at Massachusetts General Hospital, is quoted.
